PharmaLeaders published “The Role of AI in Precision Medicine: The Right Drug for the Right Patient at the Right Time,” featuring AiCure’s Chief Medical Officer, Rich Christie, in a forward-looking piece on AI’s unique potential to transform drug development through precision medicine by delivering the timely, accurate behavioral insights needed to drive informed interventions, understand which patients will be able to contribute quality data for specific studies, and bridge clinical findings in an increasingly diverse real-world environment.
-
Share
-
Recent Press
-
Jul 29, 2026
AICure Expands Executive Leadership to Accelerate AI-Powered Medication Adherence, Remote Weight Verification, and Enterprise White-Label Solutions
-
Jul 21, 2026
Forbes: The AI Company Transforming Medication Adherence And Weight Loss
-
May 29, 2025
AiCure Appoints Sabina Chadha as CEO, Ed Ikeguchi Transitions to Chief Medical Officer, and Josh Wilson Promoted to COO and President
-
Jul 29, 2026